Cardiology News and Research

Latest Cardiology News and Research

Cardiac Science launches CareCenter MD PC-based diagnostic workstation

Cardiac Science Corporation, a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, today expands its ECG and cardiac stress product lines with CareCenter MD, a multimodality PC-based diagnostic workstation designed for today's physician practices.

13 Jul 2010

Strategies to prevent HACs, reduce cost of care, improve patient experience discussed at QUEST National Meeting

As healthcare providers prepare for the implications of reform, the more than 200 hospitals participating in the QUEST: High Performing Hospitals collaborative are already achieving the goals of improving patient care and reducing costs.

13 Jul 2010

New approach in treating heart attack, cardiomyopathy using stem cells

Presenting at the UK National Stem Cell Network annual science conference today (13 July), Professor Michael Schneider describes a new approach to treating heart attack and cardiomyopathy using stem cells.

13 Jul 2010

Mortality rate of heart failure patients at Loyola is 24% lower than national average

The 30-day mortality rate of heart failure patients at Loyola University Hospital is 24 percent lower than the national average, according to the latest data from the federal government's Hospital Compare report card.

13 Jul 2010

MagnaCare social networking campaigns raise awareness of personal health, preventive care

MagnaCare, a health plan services company with national reach, today announces that its ongoing social networking campaigns are successfully raising awareness of the importance of personal health improvement and preventive care, emphasizing issues that sometimes fall between the cracks of larger causes, and advancing the MagnaCare commitment to "Care Right Here."

13 Jul 2010

BIOTRONIK publishes final results of landmark TRUST Trial in Circulation

BIOTRONIK, the pioneer of wireless remote monitoring technologies and leading manufacturer of implantable cardiac devices, announced today that the final results of the landmark TRUST Trial (Lumax-T/Lumos-T Safely RedUceS RouTine Office Device Follow-Up) have been published in the July 27, 2010 issue of Circulation. BIOTRONIK Home Monitoring is the industry's first and most advanced wireless remote monitoring system for patients with cardiac devices.

13 Jul 2010

Early markers for metabolic syndrome in youth

Melinda Sothern, PhD, CEP, Professor of Public Health and Director of Health Promotion at LSU Health Sciences Center New Orleans, will present evidence that supports relationships seen in adolescents between insulin sensitivity and fatty liver, belly fat, and total body fat and identifies additional potential early markers of insulin resistance and metabolic syndrome in healthy 7-9 year-old children, including fat in muscle cells, blood pressure, physical activity, and birth weight.

13 Jul 2010

Behavioral change programs help lower risk for cardiovascular diseases: Scientific statement

Combining counseling, extended follow-up with a healthcare provider and self-monitoring of diet and exercise is the most effective way to help patients embrace lifestyle changes that can lower their risk for heart and blood vessel (cardiovascular) diseases, according to a scientific statement published in Circulation: Journal of the American Heart Association.

13 Jul 2010

Depression increases cardiovascular problems in men with erectile dysfunction

A new study in the Journal of Sexual Medicine found that the presence of depressive symptoms in men with erectile dysfunction constitutes a risk factor for a major cardiovascular event.

13 Jul 2010

Sleep apnea may increase risk of heart disease and death by 68%: Study

Obstructive sleep apnea (OSA) that leads to snoring and is actually caused by frequent collapse of the airway during sleep makes it difficult for sufferers to breathe for periods lasting as long as 10 seconds. Severe sufferers may have 30 such apnoeic or breathless episodes per hour that can severely disrupt sleep.

13 Jul 2010

Kid cholesterol

According to a new study published in the 12th July issue of the journal Pediatrics, one third of kids have blood cholesterol on the higher side and these levels might be overlooked with the current screening recommendations.

13 Jul 2010

Telemedicine plays important role in providing access to care for Medi-Cal members

According to US Department of Health and Human Services, compared with urban Americans, rural residents have higher poverty rates, have fewer doctors, hospitals, and other health resources, and face more difficulty getting to health services. Beginning 2014, when health care reform becomes effective, an estimated 2.4 million Californians will be newly-eligible for Medi-Cal.

13 Jul 2010

Research findings could offer new approach to diabetes therapy, nutrition experts say

Nutrition experts at Oregon State University have essentially "cured" laboratory mice of mild, diet-induced diabetes by stimulating the production of a particular enzyme. The findings could offer a new approach to diabetes therapy, experts say, especially if a drug could be identified that would do the same thing, which in this case was accomplished with genetic manipulation.

13 Jul 2010

BCN launches Healthy Blue Living Rewards to improve overall health

Introducing Healthy Blue Living Rewards, an extension of Blue Care Network's successful Healthy Blue Living product. This new product is an innovative outcome-based HMO health care plan that takes personal accountability to the next level by lowering insurance costs for people who succeed in improving their health and thereby making health care more affordable.

13 Jul 2010

Study explores direct role of FTO gene on Alzheimer's and dementia risk in old age

A gene known as FTO, which appears to be correlated with obesity in humans, may also increase risk of Alzheimer's disease and dementia, according to new research presented today at the Alzheimer's Association International Conference on Alzheimer's Disease 2010 in Honolulu, HI. And when a person has certain variants of both FTO and a recognized Alzheimer's risk gene known as APOE, the risk of Alzheimer's could be doubled.

13 Jul 2010

GE Healthcare Medical Diagnostics reintroduces Optison ultrasound contrast agent for echocardiograms

GE Healthcare Medical Diagnostics today announced the market reintroduction of Optison™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent for use in select echocardiograms. Optison is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricular endocardial borders. The safety and efficacy of Optison with exercise stress or pharmacologic stress testing have not been established.

12 Jul 2010

Accumetrics, Daiichi Sankyo, Eli Lilly collaborate to raise awareness about antiplatelet therapy

Accumetrics, Inc., Daiichi Sankyo, Inc, and Eli Lilly and Company announced today that the companies have entered into a strategic collaboration in the United States to raise awareness about antiplatelet therapy and the role of platelet function testing.

12 Jul 2010

Syntermed releases NeuroQ version 3.5 for analysis, image display of brain FDG-PET scans

At the Alzheimer's Association 2010 International Conference (ICAD) July 10-14 in Honolulu, HI, Syntermed, Inc. launched NeuroQ™ version 3.5, a nuclear medicine quantitative software platform for analysis and image display of brain FDG-PET scans. NeuroQ can increase physician accuracy in diagnosing and differentiating the many types of dementia, compared to visual interpretation alone of FDG-PET.

12 Jul 2010

Reata funds second pivotal trial of bardoxolone with $78 million equity financing

Reata Pharmaceuticals, Inc. has completed a $78 million equity financing led by existing investors CPMG, Inc. and Novo A/S. This financing brings the total raised by the Company to $180 million since inception.

12 Jul 2010

Theragenics signs supply agreement with Oncura for TheraSeed palladium-103 brachytherapy seeds

Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced that it has signed an agreement with Oncura, Inc. for the distribution of TheraSeed® palladium-103 brachytherapy seeds. Oncura is a unit of GE Healthcare. Under the terms of the agreement, Theragenics will be the exclusive palladium-103 seed supplier to Oncura, subject to certain pre-existing vendor agreements, for the treatment of prostate cancer in the U.S. and Canada.

12 Jul 2010

Cardiology News and Research

Latest Cardiology News and Research

Cardiac Science launches CareCenter MD PC-based diagnostic workstation

Strategies to prevent HACs, reduce cost of care, improve patient experience discussed at QUEST National Meeting

New approach in treating heart attack, cardiomyopathy using stem cells

Mortality rate of heart failure patients at Loyola is 24% lower than national average

MagnaCare social networking campaigns raise awareness of personal health, preventive care

BIOTRONIK publishes final results of landmark TRUST Trial in Circulation

Early markers for metabolic syndrome in youth

Behavioral change programs help lower risk for cardiovascular diseases: Scientific statement

Depression increases cardiovascular problems in men with erectile dysfunction

Sleep apnea may increase risk of heart disease and death by 68%: Study

Kid cholesterol

Telemedicine plays important role in providing access to care for Medi-Cal members

Research findings could offer new approach to diabetes therapy, nutrition experts say

BCN launches Healthy Blue Living Rewards to improve overall health

Study explores direct role of FTO gene on Alzheimer's and dementia risk in old age

GE Healthcare Medical Diagnostics reintroduces Optison ultrasound contrast agent for echocardiograms

Accumetrics, Daiichi Sankyo, Eli Lilly collaborate to raise awareness about antiplatelet therapy

Syntermed releases NeuroQ version 3.5 for analysis, image display of brain FDG-PET scans

Reata funds second pivotal trial of bardoxolone with $78 million equity financing

Theragenics signs supply agreement with Oncura for TheraSeed palladium-103 brachytherapy seeds

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Cardiology News and Research

Latest Cardiology News and Research

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Newsletters you may be interested in